Sareum - Specialists in Cancer Drug Discovery
Print the page Smaller text Larger text

 

Publication of Report & Accounts
22 December, 2008

Restoration of Trading on AIM and Change of Adviser
22 December, 2008

Final Results
27 November, 2008

End of Offer Period
16 September, 2008

Resignation of Director, Update on Strategic Review
29 August, 2008

Directorate Change
11 July, 2008

Statement re. Suspension
09 July, 2008

Directorate Change
01 July, 2008

Change of Broker
26 June, 2008

Corporate Update
19 June, 2008

Restructuring
14 May, 2008

Strategic Review
02 May, 2008

Notification of Shareholder Interest
24 April, 2008

Fundraising
14 April, 2008

Financial Results
06 March, 2008

Notice of Results
04 February, 2008

 

Previous releases

2010 2009 2008 2007 2006 2005 2004

RSS news feed News feed
requires RSS news reader

2 September 2010

Sareum Holdings Plc

(“the Company”)

Holdings in Company

The Company announces, following notification received today, that following a sale of 7,000,000 ordinary shares in the capital of the Company (“Ordinary Shares”) on 1 September 2010, Mr and Mrs Leonard Licht hold a total of 47,500,000 Ordinary Shares, equivalent to 3.72 per cent. of the Company’s voting share capital.

Enquiries:

Sareum Holdings plc

 

Tim Mitchell

01223 497 700

Merchant Securities Limited

Simon Clements/Bidhi Bhoma

020 7628 2200

Hybridan LLP

 

Claire Noyce

020 7947 4350

 



Requires RSS news reader

Requires MS Word

Requires Adobe Acrobat Reader


site map

email: info@sareum.co.uk tel: +44 (0) 1223 497700 fax: +44 (0) 1223 497701